Pfizer, Inc. Press Releases

PFE 
$30.07
*  
0.07
0.23%
Get PFE Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PFE After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics
7/7/2014 7:30:00 AM - PR Newswire

Eliquis® (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
6/27/2014 7:00:00 AM - Business Wire

Pfizer Declares 26-Cent Third-Quarter 2014 Dividend
6/26/2014 11:20:00 AM - Business Wire

James C. Smith Elected to Pfizer’s Board of Directors
6/26/2014 9:45:00 AM - Business Wire

Pfizer Invites Public to View and Listen to Webcast of July 29 Conference Call with Analysts
6/24/2014 10:00:00 AM - Business Wire

Two-Year Results From Pfizer’s XELJANZ® (Tofacitinib Citrate) ORAL Start Study Published in The New England Journal of Medicine
6/18/2014 5:01:00 PM - Business Wire

Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration
6/18/2014 1:00:00 AM - Business Wire

Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine
6/17/2014 8:00:00 AM - Business Wire

Xybion Announces Pristima Selected by Pfizer Inc. for its Drug Safety R&D Data Management Solution
6/16/2014 1:55:00 PM - Business Wire

Pfizer Opens New State-of-the-Art Research and Development Site in Cambridge, Massachusetts
6/16/2014 8:00:00 AM - Business Wire

Dyadic Appoints Michael Tarnok, Chairman Of Keryx And Former Pfizer Senior Vice President, To Board Of Directors
6/12/2014 9:15:00 AM - PR Newswire

ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1
6/12/2014 6:17:00 AM - PR Newswire

Pfizer Announces Over 10 Abstracts for XELJANZ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting
6/11/2014 8:00:00 AM - Business Wire

National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.
6/10/2014 7:00:00 AM - PR Newswire

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
6/4/2014 10:00:00 AM - Business Wire

KineMed Collaboration with Pfizer Inc. in Diabetes is Extended
6/4/2014 6:00:00 AM - Business Wire

Data Review on Active Stocks -- Research on SIRIUS XM, Twitter, Pfizer, and Vale
6/3/2014 8:30:00 AM - PR Newswire

Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research
5/29/2014 11:14:00 AM - Business Wire

Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development
5/29/2014 8:30:00 AM - Business Wire

Pfizer and the Avon Foundation for Women Announce $1 Million Grants Program to Address Gaps in Support for People Living with Metastatic Breast Cancer
5/29/2014 8:00:00 AM - Business Wire

Nodality, Inc. Announces Publication of Promising Data in Melanoma in Journal of Translational Medicine
5/28/2014 8:00:00 AM - Business Wire

Pfizer Brings Frequent Heartburn Relief Over-the-Counter with New Nexium® 24HR
5/27/2014 8:30:00 AM - Business Wire

Statement from Pfizer Inc.
5/26/2014 10:05:00 AM - Business Wire

Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis
5/23/2014 9:13:00 AM - Business Wire

New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace
5/21/2014 8:15:00 AM - Business Wire